Y-Biologics, Inc. (KOSDAQ:338840)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,550
+450 (3.44%)
At close: Jun 11, 2026

Y-Biologics Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
212,341347,578113,678230,299--
Market Cap Growth
82.06%205.76%-50.64%---
Enterprise Value
186,800324,452102,035230,749--
Last Close Price
13990.0022900.007690.0015600.00--
PS Ratio
76.17119.3219.7366.19--
PB Ratio
9.4713.075.798.86--
P/TBV Ratio
9.6913.336.279.94--
EV/Sales Ratio
67.01111.3817.7166.33--
Debt / Equity Ratio
0.700.560.040.110.250.21
Net Debt / Equity Ratio
-1.14-1.11-0.58-0.69-0.40-0.39
Net Debt / EBITDA Ratio
2.864.021.782.310.510.73
Net Debt / FCF Ratio
3.184.301.632.310.720.66
Asset Turnover
0.080.080.220.120.120.11
Quick Ratio
16.0835.9310.587.391.602.91
Current Ratio
16.4536.1610.737.481.703.20
Return on Equity (ROE)
-221.97%-181.79%-28.23%-90.84%-77.73%-54.50%
Return on Assets (ROA)
-18.45%-14.95%-20.30%-21.27%-34.84%-24.67%
Return on Capital Employed (ROCE)
-21.20%-17.00%-41.10%-37.00%-90.60%-54.20%
Earnings Yield
-20.94%-12.09%-5.67%-9.06%--
FCF Yield
-3.79%-1.98%-6.16%-3.39%--
Buyback Yield / Dilution
-1.37%-0.80%-18.01%-1.87%-1.01%-21.93%